A multicohort genetic association study found that the ancestry-enriched CD36 Y325* variant accounted for a greater population-level burden of dilated cardiomyopathy (DCM) among individuals of predominantly African ancestry than truncating variants in TTN, the most common established monogenic cause of DCM. Across four US cohorts involving 82,623 individuals of predominantly African ancestry, including 1,316 DCM cases, homozygous carriers of CD36 Y325* had 4.8-fold higher odds of DCM, while heterozygous carriers had 1.4-fold higher odds. Although TTN truncating variants were associated with a higher individual risk of DCM (odds ratio, 8.5), the population attributable fraction for CD36 Y325* was 9.0%, compared with 3.7% for TTN truncating variants. These findings highlight the substantial contribution of ancestry-specific genetic variation to DCM risk and underscore the importance of diverse representation in genomic research to improve understanding of disease susceptibility. Source: https://jamanetwork.com/
A longitudinal study of 995 U.S. older adults found that frequent and unintentional daytime napping…
An American College of Cardiology scientific statement emphasizes that exercise should be prescribed as a…
A 16-week low-fat vegan diet was associated with significant reductions in body weight, visceral fat,…
A systematic review and meta-analysis of 27 studies involving 88,830 participants found that intensive blood…
In an international multicenter cohort of 4,302 individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)…
Preventive PCI was associated with a substantially lower risk of major cardiac events in patients…
This website uses cookies.